BioSpace News Archive

Business

Soligenix Announces Appointment of Mark Pearson to its Board of Directors

Soligenix intends to leverage Mr. Pearson’s extensive business and investing experience

July 24, 2018
·
6 min read
Drug Development

Janssen Presents Switch Data for New HIV-1 Treatment SYMTUZA™ (D/C/F/TAF) and Second Study Supporting its Use in a Rapid Initiation Scenario

Phase 3 EMERALD and DIAMOND studies at AIDS 2018 reinforce the safety and efficacy of the first darunavir-based HIV-1 single-tablet regimen

July 24, 2018
·
15 min read
Pharm Country

The Atlantic Philanthropies Announces Full Cohort of Atlantic Fellows

Hundreds of changemakers working to solve pressing inequality issues around the world.

July 24, 2018
·
6 min read
Business

Business Figures for the First Half of 2018: Sartorius Records Double-Digit Sales Growth

Group sales revenue up 11.9%; order intake up 12.7%; earnings margin1) 25.0%

July 24, 2018
·
9 min read
Juniper Research: Mobile Biometrics to Authenticate $2 Trillion of Sales by 2023, Driven by Over 2,500% Growth in Remote Biometric Transactions

Remote payments to account for 57% of all biometric transactions by 2023

July 24, 2018
·
2 min read
Business

Zecotek Restructures to Align Intellectual Property, Technology and Business Functions Across Operating Divisions

Zecotek Photonics Inc. is pleased to announce an internal restructuring to better align its intellectual property, photonics technology and business functions across its three operating divisions

July 24, 2018
·
5 min read
League Inc. raises C$62M to transform health benefits market

Strategic healthcare syndicate led by TELUS Ventures, along with Wittington Ventures, OMERS Ventures and RBC

July 24, 2018
·
4 min read
Policy

Librede Inc. Receives Patent for Cannabidiolic Acid (CBDA) Production in Yeast

Librede has been granted a new patent for the production of cannabidiolic acid (CBDA) in microorganisms.

July 24, 2018
·
2 min read
F-star Announces the Achievement of a Clinical Milestone in its Immuno-Oncology Collaboration with Merck

Enrolment and dose escalation in FS118 Phase I clinical study trigger milestone payment

July 24, 2018
·
2 min read
Drug Development

ViiV Healthcare Presents Phase III Data at AIDS 2018 from Landmark GEMINI Studies Showing Two-Drug Regimen of Dolutegravir and Lamivudine Has Similar Efficacy to a Three-Drug Regimen in Treatment Naïve HIV Patients

GEMINI 1 & 2 studies meet primary endpoint, showing two-drug regimen to be effective across high and low viral loads

July 24, 2018
·
11 min read